UnitedHealth Group Incorporated (UNH)
UnitedHealth's Moment of Truth: 3 Bullish Signals to Watch For
UnitedHealth Group NYSE: UNH has staged a formidable comeback, with its stock up over 29% in the last 90 days as investors embraced management's aggressive turnaround strategy. This powerful rally has built high expectations, and the market now looks to UnitedHealth Group's third-quarter earnings report on Oct. 28 for the proof needed to sustain the momentum.
What's Behind The 30% Surge In UNH Stock?
UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?
Analysts Estimate UnitedHealth Group (UNH) to Report a Decline in Earnings: What to Look Out for
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth: Bargaining Power And Tariff-Driven Generics Could Improve Margins
UnitedHealth: Bargaining Power And Tariff-Driven Generics Could Improve Margins
UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note
In the most recent trading session, UnitedHealth Group (UNH) closed at $356.67, indicating a -1.24% shift from the previous trading day.
UnitedHealth's Path To Redemption: A Buy Amid The Storm
UnitedHealth Group (UNH) faces major headwinds, including regulatory changes, mispricing, rising care costs, and DOJ investigations, but remains a healthcare leader. UNH is aggressively repricing plans, expanding value-based care, and implementing AI to address margin pressures and operational inefficiencies. Leadership changes signal a determined turnaround effort, with insider buying and superinvestor interest underscoring confidence in UNH's recovery.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market
In the latest trading session, UnitedHealth Group (UNH) closed at $354.5, marking a -3.59% move from the previous day.
UnitedHealth Group Affiliate Atrius Health Plans to Acquire Boston-Area Primary Care Group
A UnitedHealth Group affiliate plans to acquire a Boston-area primary care group called Acton Medical Associates, Bloomberg reported Thursday (Oct. 9), citing a notice posted by the Massachusetts Health Policy Commission. Atrius Health, an affiliate of UnitedHealth Group's Optum division, has agreed to acquire the 45-doctor medical practice, according to the report.
Can Digital Workflows at Optum Rx Transform UNH's Patient Experience?
UnitedHealth drives a digital overhaul at Optum Rx, automating pharmacy workflows to boost efficiency and enrich patient care.
UNH Stock: The $76 Billion Shareholder Powerhouse
Over the past decade, UnitedHealth (NYSE: UNH) has delivered a remarkable $76 billion back to its shareholders via cash in the form of dividends and buybacks. Despite facing significant headwinds in 2025, the healthcare giant has demonstrated its resilience with the stock showing recent momentum, gaining 12% over the past month, though it remains down -29% year-to-date due to earlier challenges.
UnitedHealth Group (UNH) Laps the Stock Market: Here's Why
The latest trading day saw UnitedHealth Group (UNH) settling at $360.2, representing a +1.83% change from its previous close.
